SCHEMBL25028263

SCHEMBL25028263

CNCCc1c[nH]c2cc(F)c(OC)cc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2B P41595 2/20 0.71
HTR1A P08908 4/20 0.67
MTNR1A P48039 7/20 0.67
MTNR1B P49286 6/20 0.64
HTR2A P28223 2/20 0.59
MPO P05164 2/20 0.58
KDM4E B2RXH2 4/20 0.52
CYP2D6 P10635 3/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
NPSR1 Q6W5P4 2/20 0.52
HPGD P15428 1/20 0.52
APEX1 P27695 1/20 0.52
HSD17B10 Q99714 1/20 0.52
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
HTR2C P28335 1/20 0.51
CHRNB2 P17787 1/20 0.51
CHRNA7 P36544 1/20 0.51
CHRNA4 P43681 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028276 0.86 HTR2B (0.68) HTR2BHTR1AMTNR1AMTNR1BHTR2A
SCHEMBL2534666 0.84 HTR1A (0.72) HTR2BHTR1AMTNR1AMTNR1BHTR2A
SCHEMBL18239714 0.84 MTNR1A (0.81) HTR2BHTR1AMTNR1AMTNR1BMPO
SCHEMBL1772618 0.83 HTR2B (1.00) HTR2BHTR1AMTNR1AMTNR1BMPO
SCHEMBL25030320 0.81 HTR1A (1.00) HTR2BHTR1AMTNR1AMTNR1BHTR2A
SCHEMBL9191487 0.80 MTNR1A (1.00) HTR2BHTR1AMTNR1AMTNR1BKDM4E
SCHEMBL9121196 0.79 MTNR1A (1.00) HTR2BHTR1AMTNR1AMTNR1BKDM4E
SCHEMBL31105607 0.79 HTR2A (0.68) HTR2BHTR1AMTNR1AMTNR1BHTR2A
SCHEMBL25029591 0.77 HTR1A (0.79) HTR2BHTR1AMTNR1AMTNR1BHTR2A
Oxalic Acid SCHEMBL2540168 0.77 HTR2B (0.67) HTR2BHTR1AMTNR1AMTNR1BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118055766-A Magic and non-magic serotonin receptor agonist and its preparing process and usage 库莱恩有限责任公司 2024-05-17 CN disclosed
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor Kuleon, LLC (US) 2023-10-10 US disclosed
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor Kuleon, LLC (US) 2023-10-10 US disclosed
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR Kuleon, LLC (US) 2023-08-17 US disclosed
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR Kuleon, LLC (US) 2023-08-17 US disclosed
WO-2023018864-A1 HALLUCINOGENIC AND NON-HALLUCINOGENIC SEROTONIN RECEPTOR AGONISTS AND METHODS OF MAKING AND USING THE SAME PSILOSTERICS, LLC (US) 2023-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780807-B2 Benzoselenophene, benzothiophene, and benzofuran analogs and methods of modulating the serotonin 5-HT2C receptor HTR2C, HTR2A, HTR3C HTR2B 4/4885HTR1A 8/4885MTNR1A 124/4885
US-20230257346-A1 BENZOSELENOPHENE AND SELENOPHENOPYRIDINE ANALOGS AND METHODS OF MODULATING THE SEROTONIN 5-HT2C RECEPTOR HTR2C, HTR2A, HTR3B HTR2B 4/4885HTR1A 9/4885MTNR1A 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.